ArticleArXiv2025
Optimizing Global Genomic Surveillance for Early Detection of Emerging SARS-CoV-2 Variants.
Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobal viral threats underscore the need for effective genomic surveillance, but high costs and uneven resource distribution hamper its implementation. Targeting surveillance to international travelers in major travel hubs may offer a more efficient strategy for the early detection of SARS-CoV-2 variants.
methodsWe developed and calibrated a multiple-strain metapopulation model of global SARS-CoV-2 transmission using extensive epidemiological, phylogenetic, and high-resolution air travel data. We then compared baseline surveillance with various resource-allocation approaches that prioritize travelers, focusing on Omicron BA.1/BA.2 retrospectively and on hypothetical future variants under different emergence, transmission and vaccine effectiveness scenarios.
findingsFocusing existing surveillance resources on travelers at key global hubs significantly shortened detection delays without increasing total surveillance efforts. In retrospective analyses of Omicron BA.1/BA.2, traveler-targeted approaches consistently outperformed baseline strategies, even when overall resources were reduced. Simulations indicate that focusing surveillance on key travel hubs outperform baseline practices in detecting future variants, across different possible origins, even with reduced resources. This approach also remains effective in future pandemic scenarios with varying reproductive numbers and vaccine effectiveness.
interpretationThese findings provide a quantitative, cost-effective framework for strengthening global genomic surveillance. By reallocating resources toward international travelers in select travel hubs, early detection of emerging variants can be enhanced, informing rapid public health interventions and bolstering preparedness for future pandemics.
Identifiers
39990797PMC11844623What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.